Timothy Davis

Timothy Davis

Director/Miembro de la Junta en SI-BONE, INC. .

Fortuna: 1 M $ al 31/05/2026

56 años
Health Technology
Commercial Services
Consumer Services

Perfil

Timothy E.
Davis
is President & Chief Executive Officer at BioTissue Holdings, Inc. and Biotissue Ocular, Inc. since 2022.
Director at Active Implants LLC since 2021.
Lead Independent Director at SI-BONE, Inc. since 2008.
Director at Axis Spine Technologies Ltd. Formerly Chief Executive Officer at MicroPort Orthopedics, Inc. from 2014 to 2015.
President-OrthoRecon Business at Wright Medical Technology, Inc. from 2006 to 2014.
Senior Consultant at Gemini Consulting Group, Inc. from 1995 to 1997.
Partner at MB Venture Partners LLC from 2004 to 2006.
Vice President at Vector Asset Management, Inc. from 1997 to 2004.
Sales Specialist at Parke, Davis & Co. LLC from 1992 to 1994.
Completed undergraduate studies at Vanderbilt University.
Earned an MBA from Kellogg School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
04/06/2026 76.679 ( 0,17 % ) 1 M $ 31/05/2026

Cargos activos de Timothy Davis

EmpresasCargoInicio
SI-BONE, INC. Director/Miembro de la Junta 18/03/2008
Director/Miembro de la Junta 22/02/2017
Director Ejecutivo 27/01/2022
Director/Miembro de la Junta -
Director Ejecutivo 01/01/2022

Antiguos cargos conocidos de Timothy Davis.

EmpresasCargoFin
Director Ejecutivo 01/09/2015
Corporate Officer/Principal 01/01/2014
Inversor de Capital Privado 31/01/2006
Corporate Officer/Principal 01/01/2004
░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Ver el detalle de la experiencia de Timothy Davis.

Formación de Timothy Davis.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

49

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Finance

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN